ChemicalBook > CAS DataBase List > DEFEROXAMINE MESYLATE

DEFEROXAMINE MESYLATE

Product Name
DEFEROXAMINE MESYLATE
CAS No.
138-14-7
Chemical Name
DEFEROXAMINE MESYLATE
Synonyms
DFOM;desferal;DESFERRIOXAMINE MESYLATE;deferoxaminebmesylate;Desferioxamine mesylate;desferrioxamine mesilate;DEFEROXAMINE MESYLATE SALT;Prestwick_988;desferalmesylate;deferoxaminemesilate
CBNumber
CB4372020
Molecular Formula
C26H52N6O11S
Formula Weight
656.79
MOL File
138-14-7.mol
More
Less

DEFEROXAMINE MESYLATE Property

Melting point:
148-149°
storage temp. 
2-8°C
solubility 
H2O: 50 mg/mL
form 
powder
color 
white to off-white
Water Solubility 
Soluble to 100 mM in water
More
Less

Safety

Safety Statements 
22-24/25
WGK Germany 
2
RTECS 
UG5310000
HS Code 
29280000
Toxicity
man,TDLo,parenteral,16gm/kg/34W-I (16000mg/kg),CARDIAC: PERICARDITISGASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINEBLOOD: OTHER CHANGES,American Journal of Kidney Diseases. Vol. 10, Pg. 71, 1987.
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

Precautionary statements

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
D9533
Product name
Deferoxamine mesylate salt
Purity
powder, ≥92.5% (TLC)
Packaging
1g
Price
$142
Updated
2024/03/01
Sigma-Aldrich
Product number
252750
Product name
Deferoxamine Mesylate - CAS 138-14-7 - Calbiochem
Purity
Parenteralironchelatingagent.Commonlyusedintherapyasachelatorofferri
Packaging
1g
Price
$210
Updated
2024/03/01
Sigma-Aldrich
Product number
1166003
Product name
Deferoxamine mesylate
Purity
United States Pharmacopeia (USP) Reference Standard
Packaging
300mg
Price
$436
Updated
2024/03/01
Sigma-Aldrich
Product number
Y0001934
Product name
Deferoxamine for system suitability
Purity
European Pharmacopoeia (EP) Reference Standard
Packaging
Y0001934
Price
$218
Updated
2023/06/20
Cayman Chemical
Product number
14595
Product name
Deferoxamine (mesylate)
Purity
≥95%
Packaging
500mg
Price
$73
Updated
2024/03/01
More
Less

DEFEROXAMINE MESYLATE Chemical Properties,Usage,Production

Description

Deferoxamine is a bacterial siderophore that chelates iron. It is used to experimentally inhibit iron-dependent prolyl hydroxylases (EC50 = 17.8 μM), thus preventing the degradation of isoforms of hypoxia inducible factor during normoxia. Deferoxamine has applications in diseases that are characterized by high levels of circulating iron, such as thalassemia major.

Chemical Properties

DEFEROXAMINE MESYLATE is white or almost white powder.

Uses

chelating agent (Fe & Al)

Uses

DEFEROXAMINE MESYLATE is an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients

brand name

Desferal (Novartis).

Biochem/physiol Actions

An iron chelator used often in the studies of cell proliferation and apoptosis. Has been shown to have anti-proliferative effects on vascular smooth muscle cells in vitro and in vivo and to arrest cells in the G1 phase. Also reported to induce p53. Induces apoptosis in HL-60 cells by chelating iron. After 48 hrs treatment with 1μM deferoxamine, DNA fragmentation was apparent. Cells treated with 0.1 μM deferoxamine for as little as 24 hours were committed to apoptosis; by 48 hrs nuclear collapse was observed. In some studies it has been shown to have antioxidant properties and to protect cells against H2O2-induced damage.

Clinical Use

Chelating agent:
Acute iron poisoning
Chronic iron or aluminium overload

Veterinary Drugs and Treatments

Deferoxamine is used for the treatment of either acute or chronic iron toxicity. It is being evaluated as an iron chelator for adjunctive treatment of acute cardiac ischemia and as a chelator for aluminum toxicity. Its efficacy in treating reperfusion injuries has been disappointing.

Drug interactions

Potentially hazardous interactions with other drugs
Avoid prochlorperazine, levomepromazine and methotrimeprazine (prolonged unconsciousness).
Do not administer with blood.

Metabolism

When given parenterally desferrioxamine forms chelates with iron and aluminium ions to form ferrioxamine and aluminoxamine, respectively. The chelates are excreted in the urine and faeces via the bile. Desferrioxamine is metabolised, mainly in the plasma. Four metabolites of desferrioxamine were isolated from urine of patients with iron overload. The following biotransformation reactions were found to occur with desferrioxamine: transamination and oxidation yielding an acid metabolite, beta-oxidation also yielding an acid metabolite, decarboxylation and N-hydroxylation yielding neutral metabolites.

storage

Store at -20°C

DEFEROXAMINE MESYLATE Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

View Lastest Price from DEFEROXAMINE MESYLATE manufacturers

Henan Fengda Chemical Co., Ltd
Product
DEFEROXAMINE MESYLATE 138-14-7
Price
US $8.00-2.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
g-kg-tons, free sample is available
Release date
2024-04-24
Honest Joy Holdings Limited
Product
DeferoxaMine Mesylate 138-14-7
Price
US $0.00/KG
Min. Order
1KG
Purity
98.4%
Supply Ability
100 tons
Release date
2022-02-18
Dideu Industries Group Limited
Product
DEFEROXAMINE MESYLATE 138-14-7
Price
US $1.10/g
Min. Order
1g
Purity
0.999
Supply Ability
100 Tons min
Release date
2021-08-13

138-14-7, DEFEROXAMINE MESYLATERelated Search:


  • deferoxaminebmesylate
  • deferoxaminemesilate
  • deferoxaminemethanesulfonate
  • desferal
  • desferalmesylate
  • desferalmethanesulfonate
  • desferrioxaminebmesylate
  • Deferoxamine Mesylate (300 mg)
  • N-[5-[3-[(5-aMinopentyl)hydroxycarbaMoyl]propionaMido]pentyl]-3-[[5-(N-hydroxyacetaMido)
  • N1-(5-aMinopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyaMino)pentyl]aMino]-1,4-dioxobutyl]hydroxyaMino]pentyl]butanediaMide Methanesulfonate
  • desferrioxaminebmethanesulfonate
  • monomethanesulfonate(sa
  • propionohydroxamicacid,n-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)
  • Butanediamide, N-5-4-5-(acetylhydroxyamino)pentylamino-1,4-dioxobutylhydroxyaminopentyl-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate (salt)
  • STARCHDEFEROXAMINECONJUGATE
  • Desferrioxamine mesylate salt
  • Prestwick_988
  • Deferoxamine mesylate salt,DFOM, Deferoxamine methanesulfonate salt, Desferrioxamine mesylate salt
  • Deferoxamine Mesylate (500 mg)
  • DFOM
  • DESFERRIOXAMINE MESYLATE
  • DEFEROXAMINE MESYLATE
  • DEFEROXAMINE MESYLATE SALT
  • DEFEROXAMINE METHANESULFONATE SALT
  • N4-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxybutanediamide methanesulfonate
  • Desferioxamine mesylate
  • Deferoxamine Mesilate RS
  • desferrioxamine mesilate
  • Deferoxamine mesilate CRS
  • Deferoxamine for system suitability
  • DEFEROXAMINE MESYLATE USP/EP/BP
  • Deferoxamine Mesylate (1166003)
  • esferrioxamineBmesylate
  • N1-(5-(4-((5-Aminopentyl)amino)-4-oxobutanamido)pentyl)-N1-hydroxy-N4-(5-(N-hydroxyacetamido)pentyl)succinamide methanesulfonate
  • HIFs,neovascularization,TAMSCs,diabetes mellitus,Akt,PKB,Protein kinase B,Apoptosis,Autophagy,SH-SY5Y,Hypoxia-inducible factors,Deferoxamine,Deferoxamine Mesylate,Inhibitor,MEFs,cancer,Alzheimer’s disease,HIF-PH,Reactive Oxygen Species,BMMSCs,inhibit,HIF/HIF Prolyl-Hydroxylase,COVID-19
  • Deferiprone Impurity 3
  • Deferoxamine mesylate USP/Ph. Eur
  • 138-14-7
  • C26H52N6O11S
  • C25H48N6O8CH4O3S
  • C25H48N6O8CH4SO3
  • Inhibitors
  • DESFERAL
  • Pharmaceuticals
  • Aliphatics
  • Amines
  • Chelating Agents & Ligands
  • Intermediates & Fine Chemicals